NEGXF Dividend: NexgenRx Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

NEGXF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	17	16	13	12	11	10
Revenue Growth (YoY)	6%	23%	8%	9%	10%	11%
Cost of Revenue	3	3	3	2	2	1
Gross Profit	14	13	10	10	9	9
Selling, General & Admin	11	10	9	8	6	6
Research & Development	--	--	--	--	--	--
Operating Expenses	12	12	11	10	7	7
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1	1	0	0	2	1
Income Tax Expense	0	0	0	0	-2	0
Net Income	1	0	0	0	4	2
Net Income Growth	--	--	--	-100%	100%	--
Shares Outstanding (Diluted)	84.25	70.93	70.53	70.33	74.83	69.91
Shares Change (YoY)	10%	1%	0%	-6%	7%	0%
EPS (Diluted)	0.01	0	0	0	0.05	0.03
EPS Growth	425%	-285%	1,467%	-101%	77%	-1,110%
Free Cash Flow	2	0	1	0	3	2
Free Cash Flow Per Share	0.02	0	0.01	0	0.04	0.02
Gross Margin	82.35%	81.25%	76.92%	83.33%	81.81%	90%
Operating Margin	5.88%	6.25%	0%	0%	18.18%	10%
Profit Margin	5.88%	0%	0%	0%	36.36%	20%
Free Cash Flow Margin	11.76%	0%	7.69%	0%	27.27%	20%
EBITDA	2	2	1	1	3	1
EBITDA Margin	11.76%	12.5%	7.69%	8.33%	27.27%	10%
D&A For EBITDA	1	1	1	1	1	0
EBIT	1	1	0	0	2	1
EBIT Margin	5.88%	6.25%	0%	0%	18.18%	10%
Effective Tax Rate	0%	0%	0%	0%	-100%	0%